Texas has a growing biotechnology and pharmaceutical sector centered in Houston, Dallas, San Antonio, and Austin. Government grants, tax credits, and incentive programs for Texas biotech and pharma businesses span federal research funding, state research incentives, and workforce development programs tailored to life sciences.
NIH SBIR/STTR Programs
The National Institutes of Health operates the largest SBIR/STTR program by dollar volume, funding small businesses developing biomedical technology, therapeutics, diagnostics, and medical devices.
- Phase I: Up to $275,000 for feasibility studies, typically 6-12 months
- Phase II: Up to $1.75 million for full R&D, typically 24 months
- Fast-Track and Direct-to-Phase II: Accelerated pathways for businesses with strong preliminary data
- NIH Institutes: 27 different institutes and centers, each with specific disease and technology focus areas
CPRIT (Cancer Prevention and Research Institute of Texas)
CPRIT is a Texas-specific program funded by $6 billion in voter-approved bonds for cancer research and prevention:
- Product development awards: Grants for companies developing cancer diagnostics, therapeutics, and devices
- Company relocation/expansion awards: Incentives for life sciences companies to move to or expand in Texas
- Research grants: Funding for academic researchers that can lead to commercial partnerships
- Award amounts: Product development awards can reach $20 million or more
Federal Tax Credits for R&D
- Federal R&D Tax Credit: Credit for qualified research expenses including wages, supplies, and contract research. Particularly valuable for biotech companies with high R&D spending.
- Orphan Drug Credit: Tax credit for clinical testing expenses for drugs treating rare diseases
- Small business R&D payroll tax offset: Pre-revenue startups can apply the R&D credit against payroll taxes
Other Federal Funding Sources
- NSF SBIR/STTR: Biomedical engineering, computational biology, and biomanufacturing topics
- BARDA: Biomedical Advanced Research and Development Authority funding for medical countermeasure development
- FDA programs: Breakthrough Therapy designation, Fast Track, and Priority Review pathways that accelerate development timelines
- DOD medical research: CDMRP (Congressionally Directed Medical Research Programs) funding for defense- relevant medical research
Texas Medical Center Innovation
The Texas Medical Center in Houston — the largest medical complex in the world — operates innovation programs including TMC Innovation, TMCx accelerator, and Johnson & Johnson JLABS incubator. These programs provide biotech startups with wet lab space, mentoring, and connections to clinical institutions.
State Incentives
- Texas Emerging Technology Fund (historical): While the ETF has been wound down, its successor programs continue to support life sciences
- Sales tax exemptions: Research equipment and certain laboratory supplies may qualify for manufacturing exemptions
- Skills Development Fund: Training grants for biotech and pharma workforce development
Bottom Line
Texas biotech and pharma businesses have access to NIH SBIR funding, CPRIT cancer research grants, federal R&D tax credits, and a growing innovation ecosystem. The combination of world-class medical institutions, state research funding, and no state income tax makes Texas increasingly competitive for life sciences businesses.
Our screening report identifies which biotech, pharma, and other programs may apply to your Texas business. Start your free screening →